Frontlight ResearchEarly access
Trial site
Barts Hospital
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Bladder cancer2 trials
- Gastric and oesophageal cancer2 trials
- Pancreatic cancer2 trials
- Atrial fibrillation1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Immune thrombocytopenia (ITP)1 trial
- Melanoma1 trial
- and 4 more
- Phase
- Phase 38 trials
- Phase 23 trials
- Status
- Recruiting5 trials
- Active, not recruiting3 trials
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- Incyte Corporation2 trials
- Janssen Research & Development, LLC2 trials
- Revolution Medicines, Inc.2 trials
- Genmab1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Active, not recruiting
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Head and neck cancer1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
A Real-world Study in Participants With Smoldering Multiple Myeloma
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026